Epidemiology of disease risks in relation to vitamin D insufficiency

Progress in Biophysics and Molecular Biology

Volumn 92, Issue 1, 2006, Pages 65-79

  Grant, William B ^a  

^a Sunlight   (United States)

Author keywords

Economic burden; Hip fracture; Melanoma; Osteoporosis; Skin cancer

Indexed keywords

VITAMIN D;

AUTOIMMUNE DISEASE; BONE DISEASE; COMORBIDITY; EPIDEMIOLOGY; HUMAN; INTERNATIONAL COOPERATION; METHODOLOGY; MORTALITY; MUSCLE DISEASE; NEOPLASM; PREVALENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; VITAMIN D DEFICIENCY;

AUTOIMMUNE DISEASES; BONE DISEASES; CAUSALITY; COMORBIDITY; HUMANS; INTERNATIONALITY; MUSCULAR DISEASES; NEOPLASMS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 33744923159     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2006.02.013     Document Type: Review

References (146)

1. Allen N.E., Sauvaget C., Roddam A.W., Appleby P., Nagano J., Suzuki G., Key T.J., and Koyama K. A prospective study of diet and prostate cancer in Japanese men. Cancer Causes Control 15 (2004) 911-920
2. Bach P.B., Schrag D., Brawley O.W., Galaznik A., Yakren S., and Begg C.B. Survival of blacks and whites after a cancer diagnosis. J. Am. Med. Assoc. 287 (2002) 2106-2113
3. Ballermann, B.J., Zeidel, M.L., Gunning, M.E., Brenner, B.M., 1991. Vasoactive peptides and the kidney. In: Brenner, B.M., Rector, F.C. (Eds.), The Kidney. W.B. Saunders Co., Philadelphia, Pennsylvania, USA, 510-583.
4. Bertone-Johnson E.R., Chen W.Y., Holick M.F., Hollis B.W., Colditz G.A., Willett W.C., and Hankinson S.E. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 1991-1997
5. Berube S., Diorio C., Verhoek-Oftedahl W., and Brisson J. Vitamin D, calcium, and mammographic breast densities. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 1466-1472
6. Berube S., Diorio C., Masse B., Hebert-Croteau N., Byrne C., Cote G., Pollak M., Yaffe M., and Brisson J. Vitamin D and calcium intakes from food or supplements and mammographic breast density. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 1653-1659
7. Berwick M., Armstrong B.K., Ben-Porat L., Fine J., Kricker A., Eberle C., and Barnhill R. Sun exposure and mortality from melanoma. J. Natl. Cancer Inst. 97 (2005) 195-199
8. Bischoff-Ferrari H.A., Dawson-Hughes B., Willett W.C., Staehelin H.B., Bazemore M.G., Zee R.Y., and Wong J.B. Effect of vitamin D on falls: a meta-analysis. J. Am. Med. Assoc. 291 (2004) 1999-2006
9. Blair H.C., Zaidi M., and Schlesinger P.H. Mechanisms balancing skeletal matrix synthesis and degradation. Biochem. J. 364 (2002) 329-341
10. Bodiwala D., Luscombe C.J., French M.E., Liu S., Saxby M.F., Jones P.W., Fryer A.A., and Strange R.C. Polymorphisms in the vitamin D receptor gene, ultraviolet radiation, and susceptibility to prostate cancer. Environ. Mol. Mutagen. 43 (2004) 121-127
11. Borissova A.M., Tankova T., Kirilov G., Dakovska L., and Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int. J. Clin. Pract. 57 (2003) 258-261
12. Braun, M.M., Tucker, M.A., 1997. A role for photoproducts of vitamin D in the etiology of cutaneous melanoma? Med. Hypotheses 48, 351-354.
13. Canadian Collaborative Study Group. Timing of birth and risk of multiple sclerosis: population based study. Br. Med. J. 330 (2005) 120
14. Cantorna M.T., and Mahon B.D. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp. Biol. Med. (Maywood). 229 (2004) 1136-1142
15. Chan J.M., Giovannucci E., Andersson S.O., Yuen J., Adami H.O., and Wolk A. Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden). Cancer Causes Control 9 (1998) 559-566
16. Chaplin G. Geographic distribution of environmental factors influencing human skin coloration. Am. J. Phys. Anthropol. 125 (2004) 292-302
17. Chiu K.C., Chu A., Go V.L., and Saadm M.F. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr. 79 (2004) 820-825
18. Cross H.S., Peterlik M., Reddy G.S., and Schuster I. Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: expression of 25-hydroxyvitamin D3-1alpha-hydroxylase activity and regulation of side-chain metabolism. J. Steroid. Biochem. Mol. Biol. 62 (1997) 21-28
19. Dawson-Hughes B. Racial/ethnic considerations in making recommendations for vitamin D for adult and elderly men and women. Am. J. Clin. Nutr. 80 (2004) 1763S-1766S
20. Demay M. Muscle: a nontraditional 1,25-dihydroxyvitamin D target tissue exhibiting classic hormone-dependent vitamin D receptor actions. Endocrinology 144 (2003) 5135-5137
21. Devesa, S.S., Grauman, D.J., Blot, W.J., Pennello, G.A., Hoover, R.N., Fraumeni, J.F. Jr., 1999. Atlas of Cancer Mortality in the United States, 1950-1994. NIH Publication No. 99-4564. http://cancer.gov/atlasplus/new.html (accessed December 10, 2005)
22. Dhesi J.K., Jackson S.H., Bearne L.M., Moniz C., Hurley M.V., Swift C.G., and Allain T.J. Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing 33 (2004) 589-595
23. Drezner M.K., and Harrelson J.M. Newer knowledge of vitamin D and its metabolites in health and disease. Clin. Orthop. Relat. Res. 139 (1979) 206-231
24. Embry A.F., Snowdon L.R., and Vieth R. Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann. Neurol. 48 (2000) 271-272
25. EUROCARE Working Group. EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Ann. Oncol. (2003)
26. Forman J.P., Bischoff-Ferrari H.A., Willett W.C., Stampfer M.J., and Curhan G.C. Vitamin D intake and risk of incident hypertension: results from three large prospective cohort studies. Hypertension 46 (2005) 676-682
27. Freedman D.M., Dosemeci M., and McGlynn K. Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occup. Environ. Med. 51 (2002) 257-262
28. Garland, C.F., Garland, F.C., 1980. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int. J. Epidemiol. 9, 227-231.
29. Garland C., Shekelle R.B., Barrett-Connor E., Criqui M.H., Rossof A.H., and Paul O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1 (1985) 307-309
30. Garland C.F., Comstock G.W., Garland F.C., Helsing K.J., Shaw E.K., and Gorham E.D. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2 (1989) 1176-1178
31. Garland F.C., Garland C.F., Gorham E.D., and Young J.F. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev. Med. 19 (1990) 614-622
32. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16 (2005) 83-95
33. Giovannucci, E., 2005b. Commentary: vitamin D and colorectal cancer--twenty-five years later. Int. J. Epidemiol. (E-pub ahead of print)
34. Giovannucci E. The epidemiology of vitamin D and colorectal cancer: recent findings. Curr. Opin. Gastroenterol. 22 (2006) 24-29
35. Glowacki J., Hurwitz S., Thornhill T.S., Kelly M., and LeBoff M.S. Osteoporosis and vitamin-D deficiency among postmenopausal women with osteoarthritis undergoing total hip arthroplasty. J. Bone Joint Surg. Am. 85-A (2003) 2371-2377
36. Goldacre M.J., Seagroatt V., Yeates D., and Acheson E.D. Skin cancer in people with multiple sclerosis: a record linkage study. J. Epidemiol. Community Health 58 (2004) 142-144
37. Goldberg P., Fleming M.C., and Picard E.H. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med. Hypotheses 21 (1986) 193-200
38. Gorham E.D., Garland C.F., and Garland F.C. Acid haze air pollution and breast and colon cancer mortality in 20 Canadian cities. Can. J. Public Health 80 (1989) 96-100
39. Gorham E.D., Garland F.C., and Garland C.F. Sunlight and breast cancer incidence in the USSR. Int. J. Epidemiol. 19 (1990) 820-824
40. Gorham E.D., Garland C.F., Garland F.C., Grant W.B., Mohr S.B., Lipkin M., Newmark H.L., Giovannucci E., Wei M., and Holick M.F. Vitamin D and prevention of colorectal cancer. J. Steroid Biochem. Mol. Biol. 97 (2005) 179-194
41. Grant W.B. An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer 94 (2002) 272-281
42. Grant W.B. An estimate of premature cancer mortality in the United States due to inadequate doses of solar ultraviolet-B radiation. Cancer 94 (2002) 1867-1875
43. Grant W.B. Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res. 164 (2003) 371-377
44. Grant W.B. Geographic variation of prostate cancer mortality rates in the United States: Implications for prostate cancer risk related to vitamin D. Int. J. Cancer 111 (2004) 470-471
45. Grant W.B. Insufficient sunlight may kill 45,000 Americans each year from internal cancer. J. Cos. Dermatol. 3 (2004) 176-178
46. Grant W.B. Lower vitamin D production from solar ultraviolet-B irradiance for black Americans compared to white Americans may explain some of the difference in cancer survival rates. J. Natl. Med. 98 (2006) 357-364
47. Grant W.B., and Garland C.F. A critical review of studies on vitamin D in relation to colorectal cancer. Nutr. Cancer 48 (2004) 115-123
48. Grant W.B., and Holick M.F. Benefits and requirements of vitamin D for optimal health: a review. Altern. Med. Rev. 10 (2005) 94-111
49. Grant W.B., Garland C.F., and Holick M.F. Comparisons of estimated economic burdens due to insufficient solar ultraviolet irradiance and vitamin D and excess solar UV irradiance for the United States. Photochem. Photobiol. 81 (2005) 1276-1286
50. Guy M., Lowe L.C., Bretherton-Watt D., Mansi J.L., Peckitt C., Bliss J., Wilson R.G., Thomas V., and Colston K.W. Vitamin D receptor gene polymorphisms and breast cancer risk. Clin. Cancer Res. 10 (2004) 5472-5481
51. Hanchette C.L., and Schwartz G.G. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 70 (1992) 2861-2869
52. Harris S.S. Vitamin D in type 1 diabetes prevention. J. Nutr. 135 (2005) 323-325
53. Harris S.S., and Dawson-Hughes B. Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. Am. J. Clin. Nutr. 67 (1998) 1232-1236
54. Hayes C.E. Vitamin D: a natural inhibitor of multiple sclerosis. Proc. Nutr. Soc. 59 (2000) 531-535
55. Hayes C.E., Cantorna M.T., and DeLuca H.F. Vitamin D and multiple sclerosis. Proc. Soc. Exp. Biol. Med. 216 (1997) 21-27
56. Hayes C.E., Nashold F.E., Spach K.M., and Pedersen L.B. The immunological functions of the vitamin D endocrine system. Cell Mol. Biol. (Noisy-le-grand). 49 (2003) 277-300
57. Heaney R.P. Long-latency deficiency disease: insights from calcium and vitamin D. Am. J. Clin. Nutr. 78 (2003) 912-919
58. Heaney R.P. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am. J. Clin. Nutr. 80 (2004) 1706S-1709S
59. Hernan M.A., Olek M.J., and Ascherio A. Geographic variation of MS incidence in two prospective studies of US women. Neurology 53 (1999) 1711-1718
60. Hill, A.B., 1965. The environment and disease: Association or causation? Proc. R. Soc. Med. 58, 295-300.
61. Holick M.F. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am. J. Clin. Nutr. 79 (2004) 362-371
62. Holick M.F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr. 80 (2004) 1678S-1688S
63. Holick M.F. The vitamin D epidemic and its health consequences. J. Nutr. 135 (2005) 2739S-2748S
64. Holick M.F., Siris E.S., Binkley N., Beard M.K., Khan A., Katzer J.T., Petruschke R.A., Chen E., and de Papp A.E. Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J. Clin. Endocrinol. Metab. (2005)
65. Hollis B.W. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J. Nutr. 135 (2005) 317-322
66. Hughes A.M., Armstrong B.K., Vajdic C.M., Turner J., Grulich A.E., Fritschi L., Milliken S., Kaldor J., Benke G., and Kricker A. Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int. J. Cancer (2004)
67. Hypponen E., Laara E., Reunanen A., Jarvelin M.R., and Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358 (2001) 1500-1503
68. Iowa Women's Health Study. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 50 (2004) 72-77
69. Jablonski N.G. The evolution of human skin and skin color. Annu. Rev. Antrhopol. 33 (2004) 585-623
70. Jablonski N.G., and Chaplin G. The evolution of human skin coloration. J. Hum. Evol. 39 (2000) 57-106
71. John E.M., Schwartz G.G., Dreon D.M., and Koo J. Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971-1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol. Biomarkers Prev. 8 (1999) 399-406
72. John E.M., Schwartz G.G., Koo J., Van Den Berg D., and Ingles S.A. Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res 65 (2005) 5470-5479
73. Kanis J., Oden A., and Johnell O. Acute and long-term increase in fracture risk after hospitalization for stroke. Stroke 32 (2001) 702-706
74. Kato I., Tajima K., Kuroishi T., and Tominaga S. Latitude and pancreatic cancer. Jpn. J. Clin. Oncol. 15 (1985) 403-413
75. Keen R.W., Hart D.J., Lanchbury J.S., and Spector T.D. Association of early osteoarthritis of the knee with a Taq I polymorphism of the vitamin D receptor gene. Arthritis Rheum 40 (1997) 1444-1449
76. Koziol J.A., and Feng A.C. Seasonal variations in exacerbations and MRI parameters in relapsing-remitting multiple sclerosis. Neuroepidemiology 23 (2004) 217-223
77. Krishnan A.V., Peehl D.M., and Feldman D. The role of vitamin D in prostate cancer. Recent Results Cancer Res 164 (2003) 205-221
78. Kristal A.R., Cohen J.H., Qu P., and Stanford J.L. Associations of energy, fat, calcium, and vitamin D with prostate cancer risk. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 719-725
79. Kurtzke J.F. Geographic distribution of multiple sclerosis: An update with special reference to Europe and the Mediterranean region. Acta Neurol. Scand. 62 (1980) 65-80
80. Kurtzke J.F., Beebe G.W., and Norman J.E. Epidemiology of multiple sclerosis in US veterans: 1. Race, sex, and geographic distribution. Neurology 29 (1979) 1228-1235
81. Lamprecht S.A., and Lipkin M. Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Natl. Rev. Cancer 3 (2003) 601-614
82. Lane N.E., Gore L.R., Cummings S.R., Hochberg M.C., Scott J.C., Williams E.N., and Nevitt M.C. Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: a longitudinal study. Study of Osteoporotic Fractures Research Group. Arthritis Rheum 42 (1999) 854-860
83. Leffell, D.J., Brash, D.E., 1996. Sunlight and skin cancer. Sci. Am. 1996;275: 52-53, 56-59. http://toms.gsfc.nasa.gov/ery_uv/dna_exp.gif (accessed December 12, 2005).
84. Lefkowitz E.S., and Garland C.F. Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int. J. Epidemiol. 23 (1994) 1133-1136
85. Lemish W.M., Heenan P.J., Holman C.D., and Armstrong B.K. Survival from preinvasive and invasive malignant melanoma in Western Australia. Cancer 52 (1983) 580-585
86. Li Y.C., Kong J., Wei M., Chen Z.F., Liu S.Q., and Cao L.P. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J. Clin. Invest. 110 (2002) 229-238
87. Li Y.C., Qiao G., Uskokovic M., Xiang W., Zheng W., and Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem. Mol. Biol. 89-90 (2004) 387-392
88. Lipkin M., and Newmark H.L. Vitamin D, calcium and prevention of breast cancer: a review. J. Am. Coll. Nutr. 18 (1999) 392S-397S
89. Luscombe C.J., Fryer A.A., French M.E., Liu S., Saxby M.F., Jones P.W., and Strange R.C. Exposure to ultraviolet radiation:association with susceptibility and age at presentation with prostate cancer. Lancet. 358 (2001) 641-642
90. Maalej A., Petit-Teixeira E., Michou L., Rebai A., Cornelis F., and Ayadi H. Association study of VDR gene with rheumatoid arthritis in the French population. Genes Immun 6 (2005) 707-711
91. Matsuoka L.Y., Wortsman J., Chen T.C., and Holick M.F. Compensation for the interracial variance in the cutaneous synthesis of vitamin D. J. Lab. Clin. Med. 126 (1995) 452-457
92. McAlindon T.E., Felson D.T., Zhang Y., Hannan M.T., Aliabadi P., Weissman B., Rush D., Wilson P.W., and Jacques P. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study. Ann. Intern. Med. 125 (1996) 353-359
93. Millen A.E., Tucker M.A., Hartge P., Halpern A., Elder D.E., Guerry 4th D., Holly E.A., Sagebiel R.W., and Potischman N. Diet and melanoma in a case-control study. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 1042-1051
94. Mizoue T. Ecological study of solar radiation and cancer mortality in Japan. Health Phys 87 (2004) 532-538
95. Moan J., Porojnicu A.C., Robsahm T.E., Dahlback A., Juzeniene A., Tretli S., and Grant W. Solar radiation, vitamin D and survival rate of colon cancer in Norway. J. Photochem. Photobiol. B. 78 (2005) 189-193
96. Montero-Odasso M., and Duque G. Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone. Mol. Aspects Med. 26 3 (2005) 203-219
97. Moorman P.G., and Terry P.D. Consumption of dairy products and the risk of breast cancer: a review of the literature. Am. J. Clin. Nutr. 80 1 (2004) 5-14
98. Mosekilde L. Vitamin D and the elderly. Clin. Endocrinol. (Oxf.) 62 (2005) 265-281
99. Munger K.L., Zhang S.M., O'Reilly E., Hernan M.A., Olek M.J., Willett W.C., and Ascherio A. Vitamin D intake and incidence of multiple sclerosis. Neurology 62 (2004) 60-65
100. Need A.G., O'Loughlin P.D., Horowitz M., and Nordin B.E. Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin. Endocrinol. (Oxf.) 62 (2005) 738-741
101. Nomura A.M., Stemmermann G.N., Lee J., Kolonel L.N., Chen T.C., Turner A., and Holick M.F. Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States). Cancer Causes Control 9 (1998) 425-432
102. Nutrition Monitoring Div., 1985. Human Nutrition Information Service, US Dept. of Agriculture. Food and Nutrient Intakes: Individuals in Four Regions, Year 1977-78, Hyattsville, MD, Report No. I-3.
103. Osborne J.E., and Hutchinson P.E. Vitamin D and systemic cancer: is this relevant to malignant melanoma? Br. J. Dermatol. 147 (2002) 197-213
104. Peterlik M., and Cross H.S. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur. J. Clin. Invest. 35 (2005) 290-304
105. Pfeifer M., Begerow B., Minne H.W., Nachtigall D., and Hansen C. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J. Clin. Endocrinol. Metab. 86 (2001) 1633-1637
106. Platz E.A., Leitzmann M.F., Hollis B.W., Willett W.C., and Giovannucci E. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 15 (2004) 255-265
107. Plotnikoff G.A., and Quigley J.M. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin. Proc. 78 (2003) 1463-1470
108. Ponsonby A.L., lucas R.M., and van der Mei I.A. UVR, vitamin D and three autoimmune diseases-multiple sclerosis, type 1 diabetes, rheumatoid arthritis. Photochem. Photobiol. 81 (2005) 1267-1275
109. Poole K.E., Loveridge N., Barker P.J., Halsall D.J., Rose C., Reeve J., and Warburton E.A. Reduced vitamin D in acute stroke. Stroke 37 (2006) 243-245
110. Porojnicu A.C., Robsahm T.E., Ree A.H., and Moan J. Season of diagnosis is a prognostic factor in Hodgkin's lymphoma: a possible role of sun-induced vitamin D. Br. J. Cancer 93 (2005) 571-574
111. Potischman N., and Weed D.L. Causal criteria in nutritional epidemiology. Am. J. Clin. Nutr. 69 (1999) 1309S-1314S
112. Rajakumar K. Vitamin D, cod-liver oil, sunlight, and rickets: a historical perspective. Pediatrics 112 (2003) e132-e135
113. Rajakumar K., and Thomas S.B. Reemerging nutritional rickets: a historical perspective. Arch. Pediatr. Adolesc. Med. 159 (2005) 335-341
114. Reginster J.Y. The high prevalence of inadequate serum vitamin D levels and implications for bone health. Curr. Med. Res. Opin. 21 (2005) 579-586
115. Robsahm T.E., Tretli S., Dahlback A., and Moan J. Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control 15 (2004) 149-158
116. Roche E.F., Lewy H., Hoey H.M., and Laron Z. Differences between males and females in the seasonality of birth and month of clinical onset of disease in children with type 1 diabetes mellitus in Ireland. J. Pediatr. Endocrinol. Metab. 16 (2003) 779-782
117. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol. Sci. 22 (2001) 117-139
118. Rostand S.G. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 30 (1997) 150-156
119. Rorive M., Letiexhe M.R., Scheen A.J., and Ziegler O. Obesity and type 2 diabetes. Rev. Med. Liege. 60 (2005) 374-382 [French]
120. Salazar-Martinez E., Lazcano-Ponce E.C., Gonzalez Lira-Lira G., Escudero-De los Rios P., and Hernandez-Avila M. Nutritional determinants of epithelial ovarian cancer risk: a case-control study in Mexico. Oncology 63 (2002) 151-157
121. Salazar-Martinez E., Lazcano-Ponce E., Sanchez-Zamorano L.M., Gonzalez-Lira G., Escudero-DE Los Rios P., and Hernandez-Avila M. Dietary factors and endometrial cancer risk. Results of a case-control study in Mexico. Int. J. Gynecol. Cancer 15 (2005) 938-945
122. Schwartz G.G. Vitamin D and the epidemiology of prostate cancer. Semin. Dial. 18 (2005) 276-289
123. Smedby K.E., Hjalgrim H., Melbye M., Torrang A., Rostgaard K., Munksgaard L., Adami J., Hansen M., Porwit-MacDonald A., Jensen B.A., Roos G., Pedersen B.B., Sundstrom C., Glimelius B., and Adami H.O. Ultraviolet radiation exposure and risk of malignant lymphomas. J. Natl. Cancer Inst. 97 (2005) 199-209
124. Snijder M.B., van Dam R.M., Visser M., Deeg D.J., Dekker J.M., Bouter L.M., Seidell J.C., and Lips P. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J. Clin. Endocrinol. Metab. 90 (2005) 4119-4123
125. Soilu-Hanninen M., Airas L., Mononen I., Heikkila A., Viljanen M., and Hanninen A. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult. Scler. 11 (2005) 266-271
126. Staud R. Vitamin D: more than just affecting calcium and bone. Curr. Rheumatol. Rep. 7 (2005) 356-364
127. Strutton D.R., Stang P.E., Erbey J.R., and Lydick E. Estimated coronary heart disease attributable to insulin resistance in populations with and without type 2 diabetes mellitus. Am. J. Manag. Care 7 (2001) 765-773
128. Surveillance, Epidemiology, and End Results (SEER). 2005 Program (http://www.seer.cancer.gov) SEER*Stat Database: Incidence-SEER 9 Regs Public-Use, Nov 2004 Sub (1973-2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission.
129. Tominaga S., and Kuroishi T. Epidemiology of pancreatic cancer. Semin. Surg. Oncol. 15 (1998) 3-7
130. Tuohimaa P., Tenkanen L., Ahonen M., Lumme S., Jellum E., Hallmans G., Stattin P., Harvei S., Hakulinen T., Luostarinen T., Dillner J., Lehtinen M., and Hakama M. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int. J. Cancer 108 (2004) 104-108
131. Tuohimaa P., Golovko O., Kalueff A., Nazarova N., Qiao S., Syvala H., Talonpoika R., and Lou Y.R. Calcidiol and prostate cancer. J. Steroid Biochem. Mol. Biol. 93 (2005) 183-190
132. Uitterlinden A.G., Burger H., van Duijn C.M., Huang Q., Hofman A., Birkenhager J.C., van Leeuwen J.P., and Pols H.A. Adjacent genes, for COL2A1 and the vitamin D receptor, are associated with separate features of radiographic osteoarthritis of the knee. Arthritis Rheum 43 (2000) 1456-1464
133. Uitterlinden A.G., Fang Y., Bergink A.P., van Meurs J.B., van Leeuwen H.P., and Pols H.A. The role of vitamin D receptor gene polymorphisms in bone biology. Mol. Cell Endocrinol. 197 (2002) 15-21
134. van den Bemd G.J., and Chang G.T. Vitamin D and vitamin D analogs in cancer treatment. Curr. Drug Targets 3 (2002) 85-94
135. van der Mei I.A., Ponsonby A.L., Blizzard L., and Dwyer T. Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology 20 (2001) 168-174
136. van der Mei I.A., Ponsonby A.L., Dwyer T., Blizzard L., Simmons R., Taylor B.V., Butzkueven H., and Kilpatrick T. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ 327 (2003) 316
137. Vieth R., Ladak Y., and Walfish P.G. Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J. Clin. Endocrinol. Metab. 88 (2003) 185-191
138. Visser, M., Deeg, D.J., Lips, P. Longitudinal Aging Study Amsterdam, 2003. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J. Clin. Endocrinol. Metab. 88, 5766-5772.
139. Webb A.R., Kline L., and Holick M.F. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J. Clin. Endocrinol. Metab. 67 (1988) 373-378
140. Weed D.L. On the use of causal criteria. Int. J. Epidemiol. 26 (1997) 1137-1141
141. Weisberg P., Scanlon K.S., Li R., and Cogswell M.E. Nutritional rickets among children in the United States: review of cases reported between 1986 and 2003. Am. J. Clin. Nutr. 80 (2004) 1697S-1705S
142. Willis J.A., Scott R.S., Darlow B.A., Lewy H., Ashkenazi I., and Laron Z. Seasonality of birth and onset of clinical disease in children and adolescents (0-19 years) with type 1 diabetes mellitus in Canterbury, New Zealand. J. Pediatr. Endocrinol. Metab. 15 (2002) 645-647
143. Wingerchuk D.M., Lesaux J., Rice G.P., Kremenchutzky M., and Ebers G.C. A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 76 (2005) 1294-1296
144. Zehnder D., Bland R., Williams M.C., McNinch R.W., Howie A.J., Stewart P.M., and Hewison M. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J. Clin. Endocrinol. Metab. 86 (2001) 888-894
145. Zhou W., Suk R., Liu G., Park S., Neuberg D.S., Wain J.C., Lynch T.J., Giovannucci E., and Christiani D.C. Vitamin D is associated with improved survival in early stage non-small cell lung cancer patients. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 2303-2309
146. Zittermann A., Schleithoff S.S., and Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br. J. Nutr. 94 (2005) 483-492